Rebecca Shilling

Rebecca Shilling has extensive work experience in the field of medicine and pharmaceuticals. Rebecca is currently working as a Senior Medical Director at argenx since September 2021. Prior to this, they held roles at Alnylam Pharmaceuticals, Vertex Pharmaceuticals, University of Illinois at Chicago, Indiana University School of Medicine, and University of Chicago Medicine, where they served in various professor and director positions.

Rebecca Shilling has a Bachelor of Arts (B.A.) degree in Biology from Cornell University. Rebecca then attended Case Western Reserve University School of Medicine, where they obtained a Doctor of Medicine (MD) degree. Rebecca also completed their Internal Medicine Residency and a Fellowship in Pulmonary and Critical Care Medicine at the same institution. Rebecca further pursued a specialization in Cellular Immunology at the University of Chicago. Rebecca holds additional certification in Pulmonary Medicine from the American Board of Internal Medicine.